Clinically, low NELFA expression correlated with poorer disease-free survival in YAP-high tumors, specifically in triple-negative breast cancer.<h4>Discussion</h4>These findings identify PPP as a conserved regulatory layer modulating YAP-driven oncogenic transcription. Here, NELFA is linked to triple-negative breast carcinoma.